全文获取类型
收费全文 | 726篇 |
免费 | 44篇 |
国内免费 | 13篇 |
专业分类
儿科学 | 19篇 |
妇产科学 | 35篇 |
基础医学 | 77篇 |
口腔科学 | 4篇 |
临床医学 | 113篇 |
内科学 | 189篇 |
皮肤病学 | 2篇 |
神经病学 | 26篇 |
特种医学 | 148篇 |
外科学 | 87篇 |
综合类 | 10篇 |
一般理论 | 1篇 |
预防医学 | 11篇 |
眼科学 | 1篇 |
药学 | 33篇 |
肿瘤学 | 27篇 |
出版年
2021年 | 5篇 |
2020年 | 6篇 |
2019年 | 5篇 |
2018年 | 9篇 |
2017年 | 3篇 |
2016年 | 5篇 |
2015年 | 10篇 |
2014年 | 12篇 |
2013年 | 17篇 |
2012年 | 22篇 |
2011年 | 21篇 |
2010年 | 25篇 |
2009年 | 27篇 |
2008年 | 53篇 |
2007年 | 82篇 |
2006年 | 20篇 |
2005年 | 32篇 |
2004年 | 39篇 |
2003年 | 25篇 |
2002年 | 24篇 |
2001年 | 19篇 |
2000年 | 18篇 |
1999年 | 16篇 |
1998年 | 19篇 |
1997年 | 13篇 |
1996年 | 14篇 |
1995年 | 9篇 |
1994年 | 22篇 |
1993年 | 20篇 |
1992年 | 19篇 |
1991年 | 13篇 |
1990年 | 14篇 |
1989年 | 20篇 |
1988年 | 21篇 |
1987年 | 24篇 |
1986年 | 14篇 |
1985年 | 7篇 |
1984年 | 5篇 |
1983年 | 3篇 |
1981年 | 4篇 |
1980年 | 8篇 |
1979年 | 8篇 |
1978年 | 3篇 |
1975年 | 2篇 |
1974年 | 4篇 |
1973年 | 2篇 |
1971年 | 3篇 |
1969年 | 2篇 |
1967年 | 2篇 |
1961年 | 3篇 |
排序方式: 共有783条查询结果,搜索用时 0 毫秒
21.
Barquinero J; Kiem HP; von Kalle C; Darovsky B; Goehle S; Graham T; Seidel K; Storb R; Schuening FG 《Blood》1995,85(5):1195-1201
We have studied the role of different conditioning regimens for engraftment of genetically marked hematopoietic repopulating cells in dogs. Peripheral blood (PB) and/or marrow cells collected after treatment with recombinant canine stem cell factor (rcSCF) or cyclophosphamide were transduced in a vector-containing long-term culture system. Three different vector-producing cell lines with similar viral titers were used. In two of them, the neo-containing LN vector was packaged either in the PA317 cell line with an amphotropic murine retrovirus envelope or the PG13 cell line with the gibbon ape leukemia virus (GALV) envelope. The MFG/GC vector produced in PA317 cells contained the human glucocerebrosidase gene. Nineteen dogs received either no conditioning (group A, n = 5), irradiation to both humeri with 1,000 cGy (group B, n = 5), a sublethal dose of cyclophosphamide 40 mg/kg (group C, n = 4), a sublethal dose of 200 or 300 cGy total body irradiation (TBI) (group D, n = 3), or an otherwise lethal dose of 920 cGy TBI (group E, n = 3) before intravenous (groups A, C, D, E) or intramedullary (group B) infusion of the transduced autologous hematopoietic cells. Transduction efficiency of hematopoietic cells at the time of infusion into the animals was similar among the different conditioning groups. Dogs were observed for at least 6 months. PB granulocytes were obtained at least every 3 weeks after transplant and analyzed by polymerase chain reaction for the presence of the transduced genes. The percentages of positive results in dogs more than 4 weeks after transplantation were 0% without conditioning, 5% with local irradiation, 18% with sublethal cyclophosphamide, 33% with sublethal TBI, and 17% with otherwise lethal TBI. Analyzing the influence of conditioning regimens by a generalized estimating equation (GEE) technique, which considered the use of different retrovirus vectors and the number of mononuclear cells infused as potential confounding variables, we found that engraftment of genetically marked repopulating cells was significantly improved (P < .001) in dogs receiving systemic conditioning with either otherwise lethal TBI, sublethal TBI, or sublethal cyclophosphamide compared to dogs with local irradiation only or no conditioning. Within the limitation of the experimental design, these data suggest that myeloablative or myelosuppressive conditioning improves engraftment of genetically marked hematopoietic repopulating cells. 相似文献
22.
Interaction of Mycoplasmas with Cell Cultures, as Visualized by Electron Microscopy 总被引:6,自引:2,他引:6 下载免费PDF全文
Susan Brown Marlyn Teplitz Jean-Paul Revel 《Proceedings of the National Academy of Sciences of the United States of America》1974,71(2):464-468
Mycoplasmas were examined on the surfaces of tissue culture cells prepared for transmission and scanning electron microscopy. The pleomorphic bodies seen were proved to be mycoplasmas by the use of thin sections, passage of the infection from one cell line to another, and by autoradiography with [(3)H]thymidine both on the sections and the replicas. The mycoplasmas were not always evenly distributed over the cell's surface; their arrangement seemed to correlate with the activity or morphology of the cell. The use of replicas and scanning electron microscopy in routine examination of cultures for mycoplasma contamination is discussed. 相似文献
23.
Prunier F Revel F Hemery Y Glaser E Beaufils P 《Archives des maladies du coeur et des vaisseaux》2000,93(11):1333-1338
Primary cardiac lymphoma is very rare. Secondary localisations are more common, observed in 15 to 30% of autopsy series. Clinical symptoms of cardiac involvement are rare, explaining the usual post-mortem diagnosis. The presentation of cardiac involvement by arrhythmias and conduction defects is very uncommon. The authors report two cases, the first of a 35 year old man in whom primary cardiac lymphoma presented with ventricular tachycardia complicated secondarily by complete atrioventricular block (AVB) with pseudo-inferior wall infarction. The second case was a 37 year old man with a cutaneous T cell lymphoma in whom complete AVB was the first sign of a secondary cardiac localisation of his disease. The finding of cardiac lymphoma should lead to aggressive chemotherapy as soon as possible. 相似文献
24.
Storb R; Raff RF; Appelbaum FR; Deeg HJ; Graham TC; Schuening FG; Shulman H; Yu C; Bryant E; Burnett R 《Blood》1994,84(10):3558-3566
Previous studies found that bone marrow (BM) allografts from DLA- identical littermates resulted in survival of two thirds of recipient dogs after otherwise lethal doses of 450 to 600 cGy of total body irradiation (TBI) because of successful allografts or autologous recovery after rejection of the allografts. The current study asked whether survival could be further improved by treating allograft recipients with recombinant canine granulocyte colony-stimulating factor (G-CSF), stem cell factor (SCF), or G-CSF/SCF. Of 21 dogs, 14 (67%) receiving allografts but no growth factors survived, 10 with successful allografts (including 5 mixed chimeras) and 4 with autologous recovery; whereas 7 animals died, 5 from infections during BM aplasia and 2 from acute graft-versus-host disease. By comparison, 30 of 34 dogs (88%) receiving hematopoietic growth factors in addition to the BM graft survived, 17 with successful allografts (including 10 mixed chimeras) and 13 with autologous recovery; whereas 4 died, all with infection related to BM aplasia after rejection of the allograft. Survival was similar for recipients of G-CSF, SCF, or the combination of G-CSF and SCF. Logistic regression analyses, which accounted for possible effects of TBI dose, showed a trend for improved survival in dogs receiving growth factors (P = .09), no change in allogeneic engraftment (P = .74), and a slight increase in autologous recovery (P = .22). In agreement with previous data, we found that grafts of BM from DLA-identical littermates improved survival of recipient dogs exposed to low but otherwise lethal doses of TBI. A further improvement in survival could be achieved by additional treatment with G-CSF, SCF, or G-CSF/SCF. Results suggest that treatment by hematopoietic growth factors along with BM grafts should be considered for victims of radiation accidents. 相似文献
25.
26.
27.
X Thomas E Raffoux S de Botton C Pautas P Arnaud T de Revel O Reman C Terré B Corront C Gardin Q-H Le B Quesnel C Cordonnier J-H Bourhis M Elhamri P Fenaux C Preudhomme M Michallet S Castaigne H Dombret 《Leukemia》2007,21(3):453-461
In a multicenter trial, 259 young adults (15-49 years) with newly diagnosed acute myeloid leukemia (AML) were first randomized to receive a timed-sequential induction regimen given either alone (135 patients) or concomitantly with granulocyte-macrophage colony-stimulating factor (GM-CSF) (124 patients). Patients reaching complete remission (CR) were then randomized to compare a timed-sequential consolidation to a postremission chemotherapy including four cycles of high-dose cytarabine followed by maintenance courses. In the appropriate arm, GM-CSF was given concurrently with chemotherapy during all cycles of consolidation. CR rates were significantly better in the GM-CSF arm (88 vs 78%, P<0.04), but did not differ after salvage. Patients receiving GM-CSF had a higher 3-year event-free survival (EFS) estimate (42 vs 34%), but GM-CSF did not impact on overall survival. Patients with intermediate-risk cytogenetics benefited more from GM-CSF therapy (P=0.05) in terms of EFS than patients with other cytogenetics. This was also confirmed when considering only patients following the second randomization, or subgroups defined by a prognostic index based on cytogenetics and the number of courses required for achieving CR. Priming of leukemic cells with hematopoietic growth factors is a means of enhancing the efficacy of chemotherapy in younger adults with AML. 相似文献
28.
This report describes a case of acute promyelocytic leukemia (APL) M3. At diagnosis. the specific t(15;17) translocation was observed. After chemotherapy including retinoic acid. a complete remission was achieved and the karyotype became normal. At relapse of the M3 leukemia, the t(15;17) clone was no longer observed but a t(3;6) translocation was then detected. Several hypotheses for this unusual cytogenetic course of APL are discussed. 相似文献
29.
Bauduceau O De Revel T Fogelman J Amadou S Souleau B Nedellec G 《Annales de médecine interne》2003,154(3):183-186
Spontaneous hematoma in the ilio-psoas muscle is an uncommon condition, usually observed as a complication of anticoagulation or hemophilia. Clinically, the onset is marked by violent pain in the territory of femoral nerve and/or psoitis. The diagnosis is confirmed by echography or CT-scan. The most serious complications are loss of self-sufficiency and neuro-muscular after-effect. Surgery is recommended in patients with neurological suffering, followed by early physiotherapy. We report the case of a 42-year-old man, with an ilio-psoas muscle hematoma, revealing chronic myeloid leukemia, without any hemostasis disorder. 相似文献
30.